Revvity Sites Globally
Select your location.
*e-commerce not available for this region.
Application Note
2D OncoSignature™ long-term assay: extending the reach of cell panel screens
This application note describes the development of our 2D OncoSignature™ Long-Term Assay (LTA) drug discovery service which enables the profiling of slower acting or epigenetic drugs across a diverse, clinically relevant panel of cell lines.
For research use only. Not for use in diagnostic procedures.
Download Resource
2D OncoSignature™ long-term assay: extending the reach of cell panel screens